|AzPA Pharmacy Flash|
|Aug. 27, 2014|
Save $20 by registering today: Fall Conference Nov. 15
Join us at the Kroc Corps Community Center in Phoenix! The Fall Conference provides continuing education, social and networking opportunities for pharmacy professionals of all experience levels. AzPA brings you the opportunity to earn up to 6.0 CE credits, Saturday, Nov. 15. Register by Oct. 15 for the early bird discount.
Join the conversation on social media using #azpaFall.More
ASHP Honors and Awards call for nominations
This invitation is being directed to you because we believe you are in a good position to nominate individuals for ASHP recognition. This call is for nominations for the following awards:
Pharmacist and Patient-Centered Diabetes Care Certificate Training Program: Nov. 14
Don't miss this innovative and intensive certificate program focusing on the pharmacist's role in the area of diabetes management. The program emphasizes a healthcare team approach and seeks to foster the implementation of pharmaceutical care interventions that will promote disease self-management. Join us at the Kroc Corps Community Center in Phoenix Friday, Nov. 14! Register online today.More
Reminder: NCPA Steering Committee nominations are due Aug. 28
John T. Sherrer, NCPA President-elect
One of the most important duties of the incoming president of NCPA is to select members to our Steering Committees. These committees provide important feedback to NCPA's CEO and assist in determining the direction of the association by providing valuable member insights. The committees also serve to identify potential future NCPA leaders. Selecting the committees is one of my most challenging tasks as NCPA president because we have so many talented and dedicated members from which to choose and a limited number of slots available on each committee.
Over the course of my years with NCPA, I have gotten to know many NCPA members, but I need your help to fill positions on certain committees.
Click here to fill out the nomination form. More
Nominate a colleague for recognition by the American Pharmacists Association!
The APhA Awards and Honors Program is the profession's most comprehensive recognition program. Help us identify the students, practitioners, scientists and organizations most deserving of recognition at the 2015 APhA Annual Meeting & Exposition in San Diego, California. Click here for information. Deadline: Sept. 1.More
2015 APhA Election: Lead. Make Change Happen.
The American Pharmacists Association is seeking leaders to help shape the profession's future. On the Board of Trustees, APhA President-elect and Trustee positions are both available. The available Academy positions are as follows: APhA-APRS Basic Sciences Chair-elect, Clinical Sciences Chair-elect and Economic, Social & Administrative Sciences Chair-elect are open for APhA pharmaceutical scientists and researchers; and APhA-APPM President-elect and Member-at-Large positions are open for APhA pharmacy practitioners. Click here for additional information on available positions. Deadline: Oct. 1.More
New thinking needed for superbug treatments
By Mike Wokasch
Not a day goes by without reading or hearing about the seemingly impossible task of finding effective new treatments against "superbugs" that are resistant to existing drugs. The dearth of prospects for treating these superbugs is often blamed on the lack of investment and market economics. Sure, more investment-friendly healthcare market opportunities might lure additional pharma companies and money to the effort, but there is an even bigger factor standing in the way of conquering this medical dilemma.More
Hydrocodone moved to Schedule II in DEA final rule
The Drug Enforcement Agency recently published a final rule moving hydrocodone combination products from Schedule III to Schedule II, effective Oct. 6. APhA and most pharmacy groups strongly opposed the move. The controversial scheduling change was recommended by the Assistant Secretary for Health of the U.S. Department of Health & Human Services and supported by DEA's own evaluation of relevant data, according to the recent DEA news release.More
Retail pharmacy and 5 profitability problems
By Jason Poquette
The news hit me like a ton of bricks: "All EasyCare pharmacies will be closing beginning Aug. 20. All active prescriptions will be transferred to convenient ..." What? Just like that? Yep. A small group of 11 pharmacies in central Massachusetts — all connected to Reliant Medical Group — is closing its doors. Sadly, this sort of thing happens all the time. But these pharmacies were close to home and staffed by folks I know and pharmacists I have worked with in the past. The challenge to maintain profitability in retail pharmacy suddenly became even more real.More
Walgreens pharmacy database crashes temporarily, blocking prescriptions
Walgreen Co.'s pharmacy database crashed Aug. 22 and remained down for several hours, blocking customers from filling prescriptions. The Illinois-based drugstore chain said the systems were restored at all of Walgreen's 8,200 pharmacies by 1 p.m., said Jim Graham a spokesman.More
Pharmacist interventions significantly improve clinical outcomes in HIV outpatients
Drug-related problems among outpatients with human immunodeficiency virus decrease significantly when pharmacists intervene, according to research published in Therapeutics and Clinical Risk Management. More
22 companies commit medical resources to fight Ebola
Pharmacy Practice News
As Ebola marches through West Africa, inadequate supplies of personal protective equipment and medical resources expose doctors, nurses and others to significant risk. In response, more than 20 healthcare companies sent critically needed items to facilitate a series of emergency shipments with logistical support from FedEx.More
Key to prescription drug misuse among young adults is likely peers, but not peer pressure
Medical News Today
Current efforts to prevent prescription drug misuse among young adults need to consider peers — but not peer pressure — according to a Purdue University study. "With the 18-29 age group we may be spending unnecessary effort working a peer pressure angle in prevention and intervention efforts. That does not appear to be an issue for this age group," said study co-author Brian Kelly, a professor of sociology and anthropology who studies drug use and youth cultures. "Rather, we found more subtle components of the peer context as influential. These include peer drug associations, peers as points of drug access, and the motivation to misuse prescription drugs to have pleasant times with friends." More
FDA approves new Gaucher disease therapy
Pharmacy Practice News
The FDA approved eliglustat for the long-term treatment of adults with Type 1 Gaucher disease, a rare genetic disorder. Eliglustat was designated an orphan drug. About 6,000 individuals in the U.S. have Type 1 Gaucher disease, which occurs because their body does not produce enough of the enzyme glucocerebrosidase. The deficiency causes fatty materials to collect in the spleen, liver and bone marrow.More